TC Biopharm (TCBP) Competitors $0.37 -0.01 (-3.40%) Closing price 03:58 PM EasternExtended Trading$0.36 -0.01 (-2.21%) As of 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipShort InterestTrends TCBP vs. UPC, BIOR, BDRX, PRFX, PXMD, TFFP, SRNE, BLPH, NEXI, and HSTOShould you be buying TC Biopharm stock or one of its competitors? The main competitors of TC Biopharm include Universe Pharmaceuticals (UPC), Biora Therapeutics (BIOR), Biodexa Pharmaceuticals (BDRX), PainReform (PRFX), PaxMedica (PXMD), TFF Pharmaceuticals (TFFP), Sorrento Therapeutics (SRNE), Bellerophon Therapeutics (BLPH), NexImmune (NEXI), and Histogen (HSTO). These companies are all part of the "pharmaceutical products" industry. TC Biopharm vs. Universe Pharmaceuticals Biora Therapeutics Biodexa Pharmaceuticals PainReform PaxMedica TFF Pharmaceuticals Sorrento Therapeutics Bellerophon Therapeutics NexImmune Histogen TC Biopharm (NASDAQ:TCBP) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment. Which has preferable earnings and valuation, TCBP or UPC? Universe Pharmaceuticals has higher revenue and earnings than TC Biopharm. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTC Biopharm$4.76M0.05-$7.35MN/AN/AUniverse Pharmaceuticals$32.31M0.03-$6.16MN/AN/A Does the media prefer TCBP or UPC? In the previous week, TC Biopharm had 1 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 1 mentions for TC Biopharm and 0 mentions for Universe Pharmaceuticals. TC Biopharm's average media sentiment score of 0.00 equaled Universe Pharmaceuticals'average media sentiment score. Company Overall Sentiment TC Biopharm Neutral Universe Pharmaceuticals Neutral Do institutionals and insiders believe in TCBP or UPC? 16.3% of TC Biopharm shares are held by institutional investors. Comparatively, 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 15.4% of TC Biopharm shares are held by company insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, TCBP or UPC? TC Biopharm has a beta of -0.13, indicating that its stock price is 113% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Does the MarketBeat Community believe in TCBP or UPC? TC Biopharm received 2 more outperform votes than Universe Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformTC BiopharmOutperform Votes266.67% Underperform Votes133.33% Universe PharmaceuticalsN/AN/A Do analysts rate TCBP or UPC? TC Biopharm presently has a consensus price target of $2.40, indicating a potential upside of 555.56%. Given TC Biopharm's stronger consensus rating and higher probable upside, equities research analysts plainly believe TC Biopharm is more favorable than Universe Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TC Biopharm 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Universe Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is TCBP or UPC more profitable? Company Net Margins Return on Equity Return on Assets TC BiopharmN/A N/A N/A Universe Pharmaceuticals N/A N/A N/A SummaryTC Biopharm beats Universe Pharmaceuticals on 7 of the 11 factors compared between the two stocks. Get TC Biopharm News Delivered to You Automatically Sign up to receive the latest news and ratings for TCBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCBP vs. The Competition Export to ExcelMetricTC BiopharmBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$242,000.00$3.01B$5.40B$9.13BDividend YieldN/A1.89%5.37%4.00%P/E RatioN/A46.0188.8317.53Price / Sales0.05295.351,284.8780.52Price / CashN/A189.5236.6032.90Price / Book0.014.004.964.69Net Income-$7.35M-$40.99M$117.89M$224.57M7 Day Performance-20.41%3.23%2.74%3.33%1 Month Performance-30.66%0.60%3.63%5.33%1 Year Performance-98.04%-0.09%27.26%22.97% TC Biopharm Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCBPTC Biopharm1.7276 of 5 stars$0.37-3.4%$2.40+555.6%-98.0%$242,000.00$4.76M0.0080UPCUniverse PharmaceuticalsN/A$0.52+4.4%N/A-98.4%$898,000.00$32.31M0.00220BIORBiora Therapeutics2.316 of 5 stars$0.16-14.2%$23.00+14,010.4%-98.2%$737,000.00$892,000.00-0.01120Gap DownBDRXBiodexa Pharmaceuticals1.8943 of 5 stars$4.28-1.4%$200.00+4,572.9%N/A$514,000.00$470,000.000.0020Positive NewsPRFXPainReform1.541 of 5 stars$3.02-7.1%$8.00+164.9%-66.4%$423,000.00N/A-0.024Positive NewsPXMDPaxMedicaN/A$0.03flatN/A-94.5%$351,000.00N/A0.002TFFPTFF Pharmaceuticals1.3479 of 5 stars$0.07flat$44.00+67,592.3%N/A$289,000.00$730,000.00-0.0119Positive NewsHigh Trading VolumeSRNESorrento TherapeuticsN/A$0.00flatN/A-98.8%$276,000.00$62.84M0.00800Analyst ForecastGap DownBLPHBellerophon Therapeutics0.4268 of 5 stars$0.01-25.5%N/A-80.5%$147,000.00$5.64M-0.0120Analyst ForecastNews CoverageGap DownNEXINexImmuneN/A$0.10-29.3%N/A-98.6%$138,000.00N/A-0.016Gap UpHSTOHistogenN/A$0.03flatN/A-92.6%$115,000.00$19,000.00-0.0120 Related Companies and Tools Related Companies Universe Pharmaceuticals Alternatives Biora Therapeutics Alternatives Biodexa Pharmaceuticals Alternatives PainReform Alternatives PaxMedica Alternatives TFF Pharmaceuticals Alternatives Sorrento Therapeutics Alternatives Bellerophon Therapeutics Alternatives NexImmune Alternatives Histogen Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TCBP) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TC Biopharm (Holdings) Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share TC Biopharm With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
